Insuman Comb 15

Insulin Human, the active ingredient in Insuman Comb 15, is an insulin presented as an injectable solution for subcutaneous use. The product is manufactured to EU standards and is prescribed by healthcare professionals for glycemic control in type 1 and type 2 diabetes mellitus.

GNH USA supplies Insuman Comb 15 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 15 is an insulin that acts on the endocrine pathway to manage diabetes mellitus.

Type 1 diabetes mellitus: provides basal and prandial insulin coverage to achieve target blood glucose levels. Type 2 diabetes mellitus: supplements endogenous insulin to improve glycemic control when oral agents are insufficient.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased adipose tissue due to improved glucose utilization. - Lipodystrophy: localized fat accumulation or loss at injection sites. - Edema: mild peripheral swelling. - Headache or fatigue.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment requiring immediate treatment. - Allergic reactions: rash, urticaria, or anaphylaxis. - Insulin antibodies: may alter insulin effectiveness. - Severe hypokalemia: low potassium levels in rare cases. - Acute pancreatitis: sudden abdominal pain with elevated enzymes. - Vision changes: transient blurred vision associated with rapid glucose shifts.

Precautions for Insuman Comb 15 include careful monitoring and patient education.

Dose adjustment: tailor insulin dose based on frequent blood glucose measurements. Hypoglycemia risk: educate patients on recognizing and treating low glucose episodes. Pregnancy safety: Category B; use only if benefits outweigh potential risks. Renal impairment: consider dose reduction and close monitoring. Concomitant medications: assess for agents that may mask hypoglycemia symptoms. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 15 may interact with several drug classes.

Major Interactions (Avoid): - Alcohol: can potentiate hypoglycemia, especially with fasting. - Beta‑blockers: may mask hypoglycemia symptoms, requiring closer glucose monitoring. - Sulfonylureas or meglitinides: additive risk of severe hypoglycemia.

Moderate Interactions (Monitor Closely): - Thiazolidinediones: may increase fluid retention, requiring weight monitoring. - ACE inhibitors or ARBs: may enhance insulin sensitivity, necessitating dose review. - Corticosteroids: can raise blood glucose, possibly requiring insulin dose increase.